Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy

Lancet

Volumn 351, Issue 9098, 1998, Pages 256-261

  Carr, Andrew ^a   Marriott, Deborah ^a   Field, Andrew ^a   Vasak, Eva ^a   Cooper, David A ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD8 ANTIGEN; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; DRUG RESPONSE; FECES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MALE; MICROSCOPY; MICROSPORIDIOSIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIREMIA;

EID: 0032562002     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)07529-6     Document Type: Article

References (33)

1. 1 Lane HC, Depper JM, Greene WC, Whalen G, Waldman TA, Fauci AS. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome: evidence for a selective defect in soluble antigen production. N Engl J Med 1985; 313: 79-84.
2. 2 Biggs BA, Hewish M, Kent S, Hayes K, Crowe SM. HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii. J Immunol 1995; 154: 6132-39.
3. 3 Orenstein JM, Fox C. Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science 1997; 276: 1857-61.
4. 4 Fahey J, Taylor JMG, Detels R, et al. The prognostic value of cellular and serological markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990; 322: 166-72.
5. 5 Pol S, Romana CA, Richard S, et al. Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. N Engl J Med 1993; 328: 95-99.
6. 6 Vakil NB, Schwartz SM, Buggy BP, et al. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 1996; 334: 19-23.
7. 7 Field AS, Canning EU, Hing MC, Verre J, Marriott DJ. Microsporidia in HIV-infected patients in Sydney, Australia: a report of 37 cases, a new diagnostic technique and the light microscopic and ultrastructure of a disseminated species. AIDS 1993; 7 (suppl 3): 27-33.
8. 8 DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med 1995; 332: 855-59.
9. 9 Flanigan T, Whalen C, Turner J, et al. Cryptosporidium infection and CD4 counts. Ann Intern Med 1992; 116: 840-42.
10. 10 Kotler DP, Francisco A, Clayton F, Scholes JV, Orenstein JM. Small intestinal injury and parasitic disease in AIDS. Ann Intern Med 1990; 113: 444-49.
11. 11 Ungar BLP, Kao TC, Burris JA, Finkelman FD. Cryptosporidium infection in an adult model: independent roles for IFN-γ and CD4+ T lymphocytes in protective immunity. J Immunol 1991; 147: 1014-22.
12. 12 Saxon A, Weinstein W. Oral administration of bovine colostrum anti-cryptosporidia antibody fails to alter the course of human cryptosporidiosis. J Parasitol 1987; 73: 413-15.
13. 13 Cozon G, Biron F, Jeannin M, Cannella D, Revillard J-P. Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis. J Infect Dis 1994; 169: 696-99.
14. 14 Sloper KS, Dourmashkin RR, Bird RB, Slavin G, Webster ADB. Chronic malabsorption due to cryptosporidiosis in a child with immunoglobulin deficiency. Gut 1982; 23: 80-82.
15. 15 White AC, Chappell CL, Hayat CS, Kimball KT, Flanigan TP, Goodgame RW. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J Infect Dis 1994; 70: 419-24.
16. 16 Bissuel F, Cotte L, Rabodonirina M, et al. Paromomycin: an effective treatment for cryptosporidial diarrhoea in patients with AIDS. Clin Infect Dis 1994; 18: 447-49.
17. 17 Harris M, Deutsch G, MacLean D, Tsoukas CM. A phase I study of letrazuril in AIDS-related cryptosporidiosis. AIDS 1994; 8: 1109-13.
18. 18 Anwar-Bruni DM, Hogan SE, Schwartz DA, Wilcox CM, Bryan RT, Lennox JL. Atovaquone is effective treatment for the symptoms of gastrointestinal microsporidiosis in HIV-1 infected patients. AIDS 1996; 10: 619-24.
19. 19 CAESAR Co-ordinating Committee. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial. Lancet 1997; 349: 1413-21.
20. 20 Danner SA, Carr A, Leonard J, et al. Safety, pharmacokinetics and preliminary efficacy of ritonavir, an inhibitor of HIV-1 protease. N Engl J Med 1995; 333: 1528-33.
21. 21 Carr A, Emery S, Kelleher A, Law M, Cooper DA. CD8+ lymphocyte responses to antiretroviral therapy of HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 320-26.
22. 22 Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of HIV-infected subjects treated with a HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996; 173: 321-29.
23. 23 Carr A, Cooper DA. HIV protease inhibitors. AIDS 1996; 10 (suppl A): 151-57.
24. 24 Cavert W, Notermans DW, Staskus K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997; 276: 960-63.
25. 25 Montagnino G, Bencini P-L, Tarantino A, Caputo R, Ponticelli C. Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol 1994; 14: 121-26.
26. 26 Meisel JL, Perera DR, Meligro C, Rubin CE. Overwhelming watery diarrhoea associated with a Cryptosporidium in an immunosuppressed patient. Gastroenterology 1976; 70: 1156-60.
27. 27 Connors M, Kovacs JA, Krevat S, et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997; 3: 533-40.
28. 28 Harp JA, Whitmire WM, Sacco R. In vitro proliferation and production of gamma interferon by murine CD4+ cells in response to Cryptosporidium parvum antigen. J Parasitol 1994; 80: 67-72.
29. 29 Rehg JE. Effect of interferon-γ in experimental Cryptosporidium parvum infection. J Infect Dis 1996; 174: 229-32.
30. 30 MacDonald TT, Spencer J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 1988; 167: 1341-49.
31. 31 Tanchot C, Lemonnier FA, Pérarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive and memory T cells. Science 1997; 276: 2057-62.
32. 32 McGowan I, Radford-Smith G, Jewell DP. Cytokine gene expression in HIV-infected intestinal mucosa. AIDS 1994; 8: 1569-75.
33. 33 Cameron B, Heath-Chiozzi M, Kravcik S, et al. Prolongation of life and prevention of AIDS complications in advanced HIV immunodeficiency with ritonavir: update. In: Abstracts of the XI International Conference on AIDS, Vancouver, Canada, July, 1996 (abstr MoB411).